Fate therapeutics reports first quarter 2020 financial results

Fate therapeutics reports first quarter 2020 financial results and highlights operational progress.q1 revenue $2.5 million.q1 revenue estimate $1.8 million -- refinitiv ibes data.cash, cash equivalents and investments as of march 31, 2020 were $219.4 million.qtrly loss per share $0.44.
FATE Ratings Summary
FATE Quant Ranking